AAK AB (AAK)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 175.90 |
|---|---|
| 52-week range | 171.60 – 277.40 |
| Return, 1 month / 3 months | −3.0% / −11.1% |
| Return, 1 year / 3 years | −34.1% / −11.3% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 27.2% |
| Worst drawdown (1 year) | -34.5% |
| Average daily value traded | 132.96M SEK |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AAK AB is a Swedish company that makes specialty vegetable oils and fats, based in Malmö. It supplies plant-based ingredients to food manufacturers, including fats for chocolate and confectionery, oils for bakery and dairy products, and solutions for plant-based alternatives. Its customers are mainly food producers and foodservice businesses that use these ingredients in their own products. The company also works with customers to develop tailored fat and oil solutions for their recipes and applications.
AAK AB trades under the code AAK on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AAK AB (AAK) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 175.90 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 439 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 34.1% and over the last three months it fell 11.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 29 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.6% | ||
| From 52-week high | -35.8% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.1% | ||
| 6-month return | -27.4% | ||
| 12-month return, skipping the last month | -32.0% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.5% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 132.96M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −7.4% |
|---|---|
| 1 month | −3.0% |
| 3 months | −11.1% |
| 6 months | −27.4% |
| 1 year | −34.1% |
| 3 years | −11.3% |
| 5 years | +0.7% |
Signals
| 50-day / 200-day average | 191.98 / 224.38 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | SEK 5.5000 |
| 9 May 2025 | SEK 5.0000 |
| 10 May 2024 | SEK 3.7000 |
| 5 May 2023 | SEK 2.7500 |
| 19 May 2022 | SEK 2.5000 |
| 10 May 2021 | SEK 2.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.